(March 25 21:00) Forbes.com
Moderna stock has declined by about -12% over the last week (five trading days), compared to the S&P 500 which is down by about -1.2% over the same period. Although there hasn’t been too much news relating to the company, Moderna stock has likely been hurt by the broader sell-off in high-growth...
You can find the original article
here